// App-Quantinova.ai

PO‐072 : Is overall survival and event free survival comparable between recently introduced GDP salvage chemotherapy compared to IVE and DHAP chemotherapy? A retrospective review of relapsed and refractory lymphoma patients in the northern region of England

Researchers

Presenter

  • L Dunning

Principal Investigators

  • J Swieton

  • C Shrubsole

  • S Gabriel

  • J Young

  • T Creasey

  • E Watts

  • S Welsh

  • G Jones

Medical Centers

  • Haematology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne

  • City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK

  • South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Gemcitabine

  • Cytarabine liposomal

  • Epirubicin

  • Ifosfamide

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved